Skip to main content
v2026.11,610 entries · CC-BY 4.0

MWPP (CASRAI)

Medical Writing Certification — Professional

LevelProfessionalMWPMWPP (CASRAI)
12
Lessons
12 modules
8
Domains
Exam blueprint
6
Exam items
Per attempt
70%
Pass mark
Fixed, uncurved
90
Retake wait
Days

What you earn

The credential itself

Pass the examination and CASRAI issues this certificate and the post-nominal MWPP (CASRAI), signed by the Programme Director and verifiable by anyone, permanently, from the code on its face.

Specimen. Issued as a signed PDF and as a machine-readable Open Badge; the holder and code shown are illustrative.
How it appears on your CV

Certifications

MWPP (CASRAI)Medical Writing, Professional

CASRAI·Issued Mar 2026·Credential ID CASRAI-MWP-2026-DDCP89

casrai.org/verify/CASRAI-MWP-2026-DDCP89

Every certificate is issued under the signature of Dr. Diana Nieves Castro, MD, Programme Director of CASRAI Certification, who sets the syllabus, blueprint and pass mark for this credential.

It certifies that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published on this page — and anyone can confirm it from the verification code, without an account and without contacting us.

About this credential

What it covers

Body of knowledge

Exam blueprint

The exam is assembled to these weights on every attempt. They are published before purchase because a blueprint you cannot see is not a blueprint.

Domains and weights8 domains · 6 scored items
DomainWeight
The medical-writing landscape, roles and document lifecycle1
8%1 item
Protocols, protocol amendments and investigator's brochures2
14%1 item
Clinical study reports and the ICH E3 structure3
14%1 item
Submission architecture: the CTD and eCTD4
10%1 item
Participant- and public-facing documents: consent, readability, lay summaries5
14%1 item
Publications from clinical data: planning, GPP 2022, authorship and disclosure6
16%1 item
Safety, benefit–risk and value documents7
10%1 item
Document quality: style authorities, QC against source, and control8
14%1 item
Total100%

Item counts are approximate. Each attempt draws a fresh form to the weights above, so the exact number of items per domain varies between attempts.

Syllabus

12 modules, 12 lessons

Every lesson and every learning outcome is listed. The lesson bodies open on enrolment; nothing else about the course is withheld.

12 modules · 12 lessons

Lesson material opens once you are enrolled. The full syllabus and every learning outcome are shown here so you can judge the coverage before you pay.

  1. Module 1

    1

    1 lesson

    1. Locked.The landscape, the two tracks, and the document lifecycleLocked

      On completion you will be able to

      • By the end, the learner can:
      • Place any named clinical document in the development lifecycle and state who owns it, who reviews it, and what consumes it downstream. [R]
      • Distinguish regulatory writing from medical communications as career tracks with different clients, deliverables, timelines and quality regimes. [R]
      • State accurately what AMWA/MWCC, EMWA, ISMPP and BELS each offer, and articulate the certificate/certification distinction in the terms those bodies themselves use. [R]
      • Analyse the confidentiality and conflict-of-interest obligations that attach to sponsor-side, CRO, agency and freelance engagements, and identify where they differ. [An]
  2. Module 2

    2

    1 lesson

    1. Locked.Scoping the assignment: source packs, contributor maps, document plansLocked

      On completion you will be able to

      • Specify the complete source pack a named document requires before drafting can responsibly begin. [A]
      • Construct a contributor and review map identifying who provides content, who reviews, who approves, and who has no standing to change the document. [C]
      • Evaluate a proposed timeline against the review cycles it actually implies, and state where it will fail. [E]
  3. Module 3

    3

    1 lesson

    1. Locked.The clinical study protocol as a documentLocked

      On completion you will be able to

      • Draft a protocol body from a supplied synopsis and statistical analysis plan with internally consistent objectives, endpoints, populations and analyses. [C]
      • Construct an objectives-and-endpoints table in which every objective has an endpoint, every endpoint has an analysis, and the primary / secondary / exploratory hierarchy is explicit. [C]
      • Analyse a supplied protocol for the six classes of internal inconsistency and produce a defect list. [An]
      • Evaluate eligibility criteria for operational workability at the site, and justify a recommended rewrite. [E]
  4. Module 4

    4

    1 lesson

    1. Locked.Protocol amendments and the investigator’s brochureLocked

      On completion you will be able to

      • Draft a protocol amendment with change, rationale, affected sections, impact on enrolled subjects, and a summary-of-changes document. [C]
      • Distinguish a substantial from a non-substantial amendment and write to the correct standard. [A]
      • Draft and update an investigator's brochure, integrating nonclinical and clinical data into a benefit–risk statement. [C]
      • Evaluate a reference safety information section for whether expectedness assessment can actually be performed against it. [E]
  5. Module 5

    5

    1 lesson

    1. Locked.ICH E3: the structure of the clinical study reportLocked

      On completion you will be able to

      • Reproduce the ICH E3 top-level section structure and place any supplied content fragment in its correct section and sub-section. [R] [A]
      • Plan a CSR from a protocol, a statistical analysis plan and a TLF package, producing a section-by-section source map. [C]
      • Analyse the sub-structure of E3 Sections 9, 11 and 12 and state what each sub-section is for. [An]
      • Evaluate whether an abbreviated report is appropriate for a supplied study and justify the conclusion. [E]
  6. Module 6

    6

    1 lesson

    1. Locked.Writing the CSR: efficacy, safety, narratives and the review cycleLocked

      On completion you will be able to

      • Write efficacy and safety text that states what the tables show, without over-claiming, under-claiming, or introducing numbers absent from source. [C]
      • Write patient narratives for deaths, other serious adverse events and discontinuations for adverse events, to a consistent template and from source. [C]
      • Analyse a supplied CSR safety section against its supplied tables and produce a discrepancy log. [An]
      • Evaluate a set of review comments and determine which to implement, which to reconcile, and which to escalate. [E]
  7. Module 7

    7

    1 lesson

    1. Locked.Submission architecture: the CTD, Module 2 and traceabilityLocked

      On completion you will be able to

      • Place any supplied clinical document in the correct Common Technical Document module. [A]
      • Draft Module 2 clinical summary and overview text from Module 5 source at the correct level of abstraction for each. [C]
      • Maintain and demonstrate traceability from a Module 2 statement back to the CSR and from the CSR back to the tables, listings and figures. [C]
      • Evaluate a supplied Module 2 summary for the failure mode of being a condensed CSR rather than a differently-argued document. [E]
  8. Module 8

    8

    1 lesson

    1. Locked.Informed consent, readability and plain-language rewritingLocked

      On completion you will be able to

      • Draft an informed consent form and participant information sheet from a supplied protocol, covering the required elements. [C]
      • Apply a defined readability method and state what it does not measure. [A]
      • Rewrite clinical and regulatory language into plain language without losing accuracy, and identify rewrites that have lost accuracy. [An]
      • Evaluate risk communication in a supplied document against numeracy principles. [E]
  9. Module 9

    10

    1 lesson

    1. Locked.Publication planning and GPP 2022Locked

      On completion you will be able to

      • Build a publication plan from a supplied clinical development plan: what is published, in what sequence, in what venue, with what author group, on what timeline. [C]
      • Apply GPP 2022 to a live publication-planning decision and state which provision governs. [A]
      • Evaluate a publication plan for selective-reporting risk. [E]
      • Analyse congress and journal rules for the interaction of embargo, encore presentation, prior publication and preprints. [An]
  10. Module 10

    11

    1 lesson

    1. Locked.Authorship, acknowledgment, ghostwriting, disclosure and AILocked

      On completion you will be able to

      • Apply the four ICMJE authorship criteria to a supplied industry-sponsored author group and produce a defensible outcome, including declining authorship. [A] [E]
      • Write acknowledgment and funding statements that disclose professional medical-writing assistance correctly. [C]
      • Identify a ghostwriting arrangement from supplied contractual and correspondence evidence, and state precisely what makes it one. [An]
      • Apply a target venue's current AI-disclosure requirement to a concrete drafting scenario. [A]
  11. Module 11

    12

    1 lesson

    1. Locked.Safety, benefit–risk and value documentsLocked

      On completion you will be able to

      • Draft a development safety update report from supplied safety data and reference safety information. [C]
      • Draft periodic benefit–risk evaluation report sections integrating exposure data, signal evaluation and benefit–risk conclusions. [C]
      • Distinguish a safety conclusion from a benefit–risk conclusion and explain why the second cannot be written from safety data alone. [An]
      • Evaluate a supplied benefit–risk narrative for concealed uncertainty. [E]
      • Analyse how the evidence standard in a value dossier differs from that in a regulatory submission. [An]
  12. Module 12

    13

    1 lesson

    1. Locked.Style authorities, QC against source, and document controlLocked

      On completion you will be able to

      • Perform and document a fact-check of a supplied document against its source: every number, every derived statement, every cross-reference, every citation. [A] [C]
      • Design a QC plan proportionate to a document's risk, stating what is 100 %-checked and what is sampled, and why. [C]
      • Resolve conflicts between a style authority, a sponsor style guide, a journal's instructions and a regulatory template, in the correct order of precedence. [E]
      • Analyse a supplied document for the failure modes that survive proofreading. [An]
      • Maintain version control, change history and approval records to a standard that would survive inspection. [A]

Assessment

How the exam works

The exam is closed-book and multiple choice. Each attempt draws a fresh form to the domain weights above, so no two attempts are the same paper and no answer key circulates. The pass mark is 70% and is fixed — there is no curve, no quota and no adjustment by cohort.

Scoring is immediate. You are shown your overall result and, for every item, the option you chose, the correct option and the reasoning behind it — whether you passed or not. A failed attempt may be retaken after 90 days. The wait exists so a retake is a second attempt at the material rather than a second attempt at remembering the paper.

Forms are assembled to the blueprint above or not at all: where a domain cannot yet be sampled to that standard, the exam declines to start rather than issue an unbalanced paper. Your material and progress are never affected, and there is no time limit on when you sit.

Passing candidates are issued a certificate with a verification code. Anyone can check that code on our public verification page without an account and without contacting us.

Certifying authority

Signed by Dr. Diana Nieves Castro, MD

CASRAI’s certification programme is academically and medically directed by Dr. Diana Nieves Castro, MD, Programme Director, who sets the syllabus and blueprint for this credential and signs every certificate issued under it.

CASRAI has maintained the terminology and reporting standards of research administration for over a decade. It assumed leadership of the CRediT contributor-roles taxonomy in 2014 and carried it through to adoption as ANSI/NISO Z39.104-2022, now in use by publishers, funders and institutions worldwide. This examination is drawn from that body of work.

What the credential certifies: that its holder passed the CASRAI examination for this course on the date shown, scored against the blueprint and pass mark published above — verifiable by anyone, permanently, from the code on its face.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →